ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
1 |
10:51 |
10:51 |
ASX - By Stock
|
181
|
70K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
7 |
10:02 |
10:02 |
ASX - By Stock
|
181
|
70K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
181
|
70K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
13 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
181
|
70K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
7 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
181
|
70K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
181
|
70K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
672 |
297K |
10 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
672
|
297K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
10 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
181
|
70K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
181
|
70K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
4 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
181
|
70K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
181 |
70K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
181
|
70K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
5 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
30 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
5 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
12 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
2 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
10 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
17K
|
6.8M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
interleukin-11
|
|
Wilba32
|
7 |
3.3K |
17 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
7
|
3.3K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
5 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
4 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
28 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
13 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
14 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
9 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
Wilba32
|
131 |
52K |
3 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
131
|
52K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
15 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
23 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
4 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
265
|
102K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
67 |
23K |
13 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
23K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
11 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
15 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
17K
|
6.8M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
2 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
102K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
102K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
4 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
102K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
7 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
265
|
102K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
11 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
265
|
102K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
33 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
102K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
17K
|
6.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
7 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
102K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
102K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
102K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
102K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.1M |
4 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
10K
|
3.1M
|
4
|
|